background image

Paid Clinical Trials Utah

Discover 1,153 paid clinical trials in Utah. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)

Recruiting
PHASE3

Sponsor:

GlaxoSmithKline

Location:

Bountiful UT, Modesto CA, Valencia CA, North Hollywood CAshow 23 more

Code:

NCT06597344

Conditions

Urinary Tract Infections

Eligibility Criteria

Sex: Female

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Gepotidacin

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

Recruiting
PHASE2

Sponsor:

Eli Lilly and Company

Location:

Murray UT, Idaho Falls ID, Glendale AZ, Phoenix AZshow 45 more

Code:

NCT05986292

Conditions

Osteoarthritis, Knee

Diabetic Neuropathic Pain

Chronic Low-back Pain

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LY3016859 ISA

LY3556050 ISA

LY3526318 ISA

LY3857210 ISA

Placebo Oral

Study of RYZ101 Compared with SOC in Pts W Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Recruiting
PHASE3

Sponsor:

RayzeBio, Inc.

Location:

Salt Lake City UT, Phoenix AZ, Duarte CA, Los Angeles CAshow 28 more

Code:

NCT05477576

Conditions

GEP-NET

Gastroenteropancreatic Neuroendocrine Tumor

Gastroenteropancreatic Neuroendocrine Tumor Disease

Neuroendocrine Tumors

Carcinoid

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RYZ101

Everolimus

Sunitinib

Octreotide

Lanreotide

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

Recruiting
PHASE2

Sponsor:

Children's Oncology Group

Location:

Salt Lake City UT, Aurora CO, Los Angeles CA, Palo Alto CAshow 13 more

Code:

NCT05504291

Conditions

Bilateral Retinoblastoma

Childhood Intraocular Retinoblastoma

Group D Retinoblastoma

Stage I Retinoblastoma

Unilateral Retinoblastoma

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Carboplatin

Etoposide

Examination Under Anesthesia

Magnetic Resonance Imaging

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Refractory Generalized Myasthenia Gravis

Recruiting
PHASE2

Sponsor:

Kyverna Therapeutics

Location:

Murray UT, Orange CA, Palo Alto CA, Miami FL

Code:

NCT06193889

Conditions

Myasthenia Gravis

Generalized Myasthenia Gravis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

KYV-101

Standard lymphodepletion regimen

Neuroblastoma Maintenance Therapy Trial

Recruiting
PHASE2

Sponsor:

Giselle Sholler

Location:

Salt Lake City UT, Boise ID, Denver CO, Oakland CAshow 42 more

Code:

NCT02679144

Conditions

Neuroblastoma

Eligibility Criteria

Sex: All

Age: 1 - 30

Healthy Volunteers: Not accepted

Interventions

Difluoromethylornithine (DFMO)

Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty

Recruiting
PHASE2

Sponsor:

Teikoku Pharma USA, Inc.

Location:

Salt Lake City UT, Anaheim CA

Code:

NCT05412992

Conditions

Pain, Postoperative

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DMTS Patch

Placebo Patch

Combination Therapy for the Treatment of Diffuse Midline Gliomas

Recruiting
PHASE2

Sponsor:

UCLA

Location:

Salt Lake City UT, Los Angeles CA, San Francisco CA, San Diego CAshow 14 more

Code:

NCT05009992

Conditions

Diffuse Intrinsic Pontine Glioma

Diffuse Midline Glioma, H3 K27M-Mutant

Recurrent Diffuse Intrinsic Pontine Glioma

Recurrent Diffuse Midline Glioma, H3 K27M-Mutant

Recurrent WHO Grade III Glioma

Eligibility Criteria

Sex: All

Age: 2 - 39

Healthy Volunteers: Not accepted

Interventions

ONC201

Radiation Therapy

Paxalisib

A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

Recruiting
PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Salt Lake City UT, Tucson AZ, Lubbock TX, Seattle WAshow 29 more

Code:

NCT05455320

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Talquetamab

Daratumumab

Pomalidomide

Dexamethasone

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting
PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Salt Lake City UT, Basalt CO, Boulder CO, Billings MTshow 62 more

Code:

NCT05147220

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

Popular cities in Utah

Offering a robust healthcare network and esteemed research institutions, Utah is a significant hub for clinical trials. Leading centers like the University of Utah Health, Huntsman Cancer Institute, and the Intermountain Healthcare system are at the forefront of medical research and innovation. Utah's strong emphasis on research and its collaborative environment make it a prominent state for conducting impactful clinical trials.

Why choose Utah for clinical trials?

Common conditions studied in Utah

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Utah